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Objective: The physicochemical properties of hydroxyapatite (HA) granules were observed to affect the biological behavior of graft materials. The aim of this work was to analyze 
the tissue response of two HA granules with different crystallinity and Ca/P ratio in vivo. 
Material and Methods: The HA granules were produced in the Biomaterials Laboratory 
(COPPE/UFRJ). The testing materials were HA granules presenting a Ca/P molar ratio of 
1.60 and 28% crystallinity (HA-1), and a Ca/P molar ratio of 1.67 and 70% crystallinity 
(HA-2). Both HAs were implanted into a critical-size calvaria rat defects. Results: To 
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and histomorphometric analyses after 1, 3, and 6 months postoperatively showed mild 
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to the similar volume density of the newly formed bone and biomaterials in relation to the 
control group. Conclusion: Thus, we concluded that HA-1 and HA-2 are biocompatible and 
non-degradable, and that crystallinity does not affect bone repair of critical size defects.
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INTRODUCTION
In the last decade, great progress was made in 
the use of grafts in dentistry with the development 
of the biomaterials that became indispensable for 
professionals in the areas of bucomaxillofacial 
surgery, paraendodontic surgery, orthognathic and 
implants surgery13. Bone loss owing to trauma or 
disease is not only a major socio-economic burden 
on world healthcare systems, but also results in 
a reduced quality of life for the patient. Current 
strategies for repair include bone autograft and 
allograft, both of which have inherent limitations 
such as limited supply, increased morbidity, and 
disease transmission potential18.
In this scenario, calcium phosphate (Ca-P) 
porous ceramics had gained acceptance and 
these are used in medical–dentistry fields in 
order to promote bone regeneration, increase, 
or substitution3. Calcium phosphate materials 
can be found in nature (coralline hydroxyapatite) 
or can be synthesized by precipitation methods 
using chemical reagents. Hydroxyapatite (HA), 
Ca10(PO4)6(OH)2, is the well-known and widely 
studied Ca-P12. In both medical and dental routine, 
the term “hydroxyapatite” is sometimes used to 
describe any Ca-P material. Synthetic Ca-P grafts 
may be the material of choice, especially when large 
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that these bioceramics are only osteoconductive 
(have the ability to support tissue growth and bone 
formation) and non-osteoinductive, i.e., they do not 
have the ability to form new bones when implanted 
in non-osseous sites17.
Based on their physic-chemical properties, 
the bone-graft material may be either resorbable 
or non-resorbable, with respect to the extent of 
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Figure 1- HA-1 and HA-2 x-ray diffraction (XRD)
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dissolution of Ca-P materials. The factors affecting 
the dissolution properties are similar to those 
affecting biodegradation or bioresorption5,12,17.
Among other physicochemical characteristics, 
HA crystallinity and Ca/P molar ratio have been 
reported to affect its solubility1,3,23, protein 
adsorption, and osteoblast attachment28, possibly 
compromising biological responses. However, no 
in vivo data are available in the literature. In order 
to achieve this point, the aim of this work is to 
analyze the tissue response of two HA granules with 
different physicochemical properties in critical-size 
calvaria rat defects4.
MATERIAL AND METHODS
Material
The HA (HA-1 and HA-2) granules (250-
1000 μm) were obtained from the HA powder, 
produced from reactive calcium phosphates at 
room temperature, in the Biomaterials Laboratory, 
COPPE, Federal University of Rio de Janeiro (Rio 
de Janeiro, RJ, Brazil). Previous analysis showed 
that HA-1 granules presented a Ca/P molar ratio 
of 1.6 and 28% crystallinity, while the HA-2 
granules had a Ca/P molar ratio of 1.67 and 70% 
crystallinity, as determined by chemical analysis 
and x-ray diffraction (XRD), respectively (Figure 
1). Morphological characterization of the materials 
was carried out with the help of scanning electron 
microscopy (Zeiss, model DSM 940A, Oberkochen, 
Baden-Württemberg, Germany) operating at 20 kV 
of electron acceleration. To identify the crystalline 
phases in the biomaterials, an x-ray diffractometer 
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radiation. The crystallinity of the materials was 
determined from the DRX patterns according to the 
methodology proposed by Landi, et al.16 (2000).
Surgical procedures 
The ethics committee of Bauru School of 
Dentistry, University of São Paulo (USP) approved 
the protocol of the surgical intervention (CEEPA - Nº 
18/2004). All the procedures were followed under 
rules of Brazilian College of Animal Experimentation 
(COBEA).
\Rattus norvegicus (250 g body 
weight) were submitted to skull surgery under 
general anesthesia with intramuscular administration 
of xylazine/ketamine (v:v, AgriBrands LtdaTM, 
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the frontoparietal region and vigorous disinfection 
with iodoform alcohol, the surgical area was isolated 
and a half moon-shaped incision was made in the 
lining epithelium of the skull with a #10 surgical 
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Molt spatula, thus widely exposing the bone surface 
of the skull. Using a surgical trephine (8 mm in 
diameter), a perforation was made in the parietal 
bone, under abundant and continuous irrigation 
with saline solution to avoid any thermal injury, 
crossing the entire diploe and exposing the dura 
mater at the bottom of the defect. The defects were 
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each. Nylon sutures (EthiconTM=	~=	
São José dos Campos, SP, Brazil) were employed to 
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received water and pelleted food ad libitum.
Histological processing
The rats were killed by an overdose of the 
anesthetic agent after 1, 3, and 6 months of surgery. 
The skullcaps with overlaying skin were collected 
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one week, demineralized in Morse solution (50% 
formic acid and 20% sodium citrate, 1:1) for 40 
days, dehydrated in ethanol, cleared with xylene, 
and embedded in HistosecTM (Merck, Darmstadt, 
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semi-serial section was used for descriptive and 
histomorphometric analysis.
Descriptive histological analysis
Using an AxioscopTM (Carl Zeiss, Darmstadt, 
Germany), we evaluated the presence of blood 
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of angiogenesis, formation of fibrous tissues, 
resorption of graft material, reorganization of the 
periosteum, and bone formation and remodeling.
Histomorphometric and statistical analysis
We determined the volume density of connective 
tissue, neoformed bone, and biomaterial on non-
superposed digital images of the total area of 
the bone defect obtained using Sony Cyber-Shot 
(P-83, Tokyo, Japan) digital camera coupled to a 
microscope (Jenaval-Zeiss, Darmstadt, Germany) 
under 20× objective (N.A. 0.55). The digital 
images (1280×960 pixels) segmentation allowed 
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Figure 2- Photomicrography of rat skulls at the periods of 1 and 6 months. A) Control group (blood clot), 1 month; the 
interface between old bone (OB) and new bone (NB) presents a line (arrow); asterisk (*) shows the connective tissue. B) 
Control group, 6 months; the old bone (OB) and new bone (NB) separated by connective tissue; interestingly, an animal of 
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of new bone (NB) and multinucleated giant cells (arrows) and connective tissue (*) were observed surrounding HA particles 
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(arrows) and multinucleated giant cells in contacting HA particles (circle). E) Section showing the border of the bone defect 
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12.5x (B, E)
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Analyzed 
Structure
Experimental Groups and Periods (months)
Control group HA-1 HA-2
1 3 6 1 3 6 1 3 6
Bone 22.2±13.4 21.8±9.5 32.4±13.0 15.2±4.7 25.9±24.7 27.2±18.0 21.2±24.0 21.1±3.9 32.0±28.7
Fibrous tissue 77.7±13.4 78.1±9.5 67.5±13.0 45.7±7.2 46.6±11.2 46.6±10.5 37.3±17.5 48.1±7.6 41.0±17.0
Biomaterial 0 0 0 38.9±11.8 27.3±14.14 26.0±9.1 41.3±8.0 30.7±4.2 26.9±11.8
Table 1- Mean percentage (± standard deviation) 
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biomaterial at 1, 3, and 6 months after implantation in critical size bone defect (ANOVA and Tukey test if p<0.05) 
Author Bone (%) Fibrous tissue (%) Biomaterial (%)
Conz, et al. (present work) 27.2 46.6 26.0
Conz, et al. (present work) 32.0 41.0 26.9
Valentín and Bensur26 (2003) 21.0 40.0 39.0
Yildirin, et al.29 (2000) 14.7 55.6 29.7
Norton, et al.22 (2003) 26.9 47.5 25.6
John and Wenz14 (2004) 29.5 55.6 14.9
Meijndert, et al.20 (2005) 17.6 41.9 40.5
Table 2-`	
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determination of the total image area and relative 
area of the connective tissue, biomaterial, and 
neoformed bone. Kruskall-Wallis or Mann-Whitney 
tests determined the existence of significant 
differences (if p<0.05) among the volume density 
of each parameter.
RESULTS
The procedures were well tolerated by all 
experimental animals and no complications were 
observed after surgery.
 
Descriptive microscopic analysis
In summary, all groups presented fibrous 
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and sparse neoformed bone areas were observed 
in all the animals, mainly at the edge of defect. No 
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and HA-2 and dense connective tissues surrounded 
the biomaterials granules except for some particles 
where a directed bone apposition to HA occurred. 
Tissue response to biomaterials, irrespective of 
crystallinity and Ca/P molar ratio, presented foreign 
body reaction with multinucleated and macrophage-
like cells, occasionally observed in contact with the 
biomaterials.
Animals from control group, one month after 
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close to the blood vessels and mononuclear cells 
(macrophages-like cells), as showed in the Figure 
2A. The presence of polymorphonuclear cells and 
mast cells was similar in HA-1, HA-2 and control 
groups (Figure 2C). The macrophages were more 
abundant surrounding the HA granules, it being 
multinucleated giant cells (Figure 2C).
The intensity of the inflammatory infiltrate 
decreased after 3 months of implantation, particularly 
concerning the presence of macrophages, but with 
increased incidence of multinucleated foreign body 
giant cells in both HA-1 and HA-2 groups (not 
shown). Polymorphonuclear cells were absent in 
all sections evaluated.
The inflammatory infiltrate disappeared in 
control group, it being that just an animal (from 
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defect after six months (Figure 2B). In both HA-1 
and HA-2 groups the microscopic aspects were 
similar to previous period, presenting mononuclear 
cells scattered through the dense connective tissue 
and multinucleated foreign body giant cells around 
both types of HA particles (Figure 2D and E).
Histomorphometric analysis
Throughout the experimental periods (Table 
1), the volume density of connective tissue in the 
control group was almost twice greater than HA-1 
and HA-2 groups (p=0.012, Student-Newman-
Keuls test). The volume density of bone between 
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experimental period remaining around 30% after 
six months. Temporal analysis from one to three 
months for volume density of connective tissue, 
J Appl Oral Sci. 341
CONZ MB, GRANJEIRO JM, SOARES GA
  |K@  |K} 	  

difference (Table 1).
DISCUSSION
Synthetic and natural Ca-P-based materials may 
be a suitable alternative to autogenous graft19. 
With various bone grafting options available to the 
surgeons, one must carefully match the clinical 
problem with the capabilities of graft material. 
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material, but when applied to bone, decreases 
remodeling and resorption capability of the 
biomaterial11,12. Among several factors, chemical 
composition, particles size, and crystallinity are 
likely to affect the ceramic solubility, which can 
be adjusted for the desired purpose7,8. Different 
applications require materials with different 
resorption rates, which can be regulated by the 
mixture of several Ca-P phases17. Crystallinity is 
highly dependent on the sintering temperature - the 
high sintering temperature results in more perfect 
crystal, and thus, the degradation rate is lesser28. 
On the other hand, more extensive interconnected 
porosity of materials permits faster bone growth, 
but it becomes the material weaker; the ideal pore 
size is considered to be between 150 and 500 
microns2,9, like those ones naturally designed30. 
Industrially, the degree of microporosity depends 
on the compaction process of the starting powder 
and the temperature for producing engineered 
materials. The presence of pores in the granules 
increases the surface area in the biomaterials, 
favoring osteoconduction, and also enabling bone 
growth in the pores30. The HA granules, from 
both HA-1 and HA-2 groups, presenting different 
crystallinity (28 and 78%, respectively) and Ca/P 
molar ratio (1.60 and 1.67, respectively) should 
present differential biological response. Thus, the 
positive hypothesis was that less crystalline and 
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bigger degradability than others.
Despite many in vivo models available for 
biocompatibility assay, only critical size defect 
studies allow the determination of biomaterial 


6,25. Critical size defect varies in relation to 
the animal species, localization and animal age; 
in rat calvaria bone defect of 5 mm4 and 8 mm10 
have been widely used. Based on our results, this 
work supports previous studies that concluded that 
bone defects of 8 mm diameter did not allow self 
regeneration up to six months5,24.
The lack of membrane over the biomaterial for 
guided bone regeneration (GBR) may explain the 
			
10,21. 
As discussed in the current literature, the different 
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groups and control group were related to the HA 
granules in the defect of the experimental groups27,31. 
GBR has been recognized as a predictable and 
effective method for enhancing bone healing over 
a decade, and both animal and human models have 
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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
15,29. It has been shown that 
the use of absorbable membrane alone was able to 
fully regenerate a critical size defect25.
The experimental groups did not show greater 
bone formation than the control group, and 
the results are similar to previous studies in 
humans14,20,22,26,29 (Table 2). It is worthwhile to 
mention that in the current literature, synthetic 
and natural hydroxyapatite promoted similar 
levels of new bone. The residual bone graft 
biomaterial in the experimental groups increased 
the mineral content inside the bone defects and 
did not interfere with the bone formation, acting 
as an osteoconductor biomaterial. However, the 
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vivo synthetic hydroxyapatites with low (28%) 
and high (70%) crystallinity and distinct Ca/P ratio 
content, showing that intensity of bone repair was 
independent of these parameters. An explanation 
of this statement is that one published recently2; 
their results revealed key steps of the mechanism 
for the bioactivity of hydroxyapatite, which are 
the solubilization of hydroxyapatite and the 
equilibrium that is formed on the surface. These 
processes modify the hydroxyapatite surface, 
whose composition is changed to a new calcium 
phosphate compound with the chemical formula of 
CaHPO4. A clear description of the transformations 
that occur on the surface of hydroxyapatite and 
of the interplay between these transformations 
and cell activity are two fundamental aspects of 
processes in which hydroxyapatite takes part, such 
as bone substitution, bone remodeling, osteoporosis 
and caries.
CONCLUSION
In conclusion, the different characteristics of 
HA granules did not affect the bone formation 
in the critical-size defect of rats, despite their 
biocompatibility. It is known that sintered 
biomaterials lead to products virtually not absorbable 
and, thus, developing new strategies to produce 
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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Taken together, these results guide the material 
engineer for producing biphasic materials containing 
beta-TCP and non-sintered hydroxyapatite as a 
potential material to provide bone growth. Another 
challenge is the production of mechanically stable 
scaffolds to support the forces applied during 
surgical procedures.
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